2673 related articles for article (PubMed ID: 32275855)
1. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.
Wang Q; Zhang Y; Wu L; Niu S; Song C; Zhang Z; Lu G; Qiao C; Hu Y; Yuen KY; Wang Q; Zhou H; Yan J; Qi J
Cell; 2020 May; 181(4):894-904.e9. PubMed ID: 32275855
[TBL] [Abstract][Full Text] [Related]
2. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.
Lan J; Ge J; Yu J; Shan S; Zhou H; Fan S; Zhang Q; Shi X; Wang Q; Zhang L; Wang X
Nature; 2020 May; 581(7807):215-220. PubMed ID: 32225176
[TBL] [Abstract][Full Text] [Related]
3. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
Wan Y; Shang J; Graham R; Baric RS; Li F
J Virol; 2020 Mar; 94(7):. PubMed ID: 31996437
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of receptor recognition by SARS-CoV-2.
Shang J; Ye G; Shi K; Wan Y; Luo C; Aihara H; Geng Q; Auerbach A; Li F
Nature; 2020 May; 581(7807):221-224. PubMed ID: 32225175
[TBL] [Abstract][Full Text] [Related]
5. On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2.
Corrêa Giron C; Laaksonen A; Barroso da Silva FL
Virus Res; 2020 Aug; 285():198021. PubMed ID: 32416259
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms.
Ali A; Vijayan R
Sci Rep; 2020 Aug; 10(1):14214. PubMed ID: 32848162
[TBL] [Abstract][Full Text] [Related]
7. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.
Yi C; Sun X; Ye J; Ding L; Liu M; Yang Z; Lu X; Zhang Y; Ma L; Gu W; Qu A; Xu J; Shi Z; Ling Z; Sun B
Cell Mol Immunol; 2020 Jun; 17(6):621-630. PubMed ID: 32415260
[TBL] [Abstract][Full Text] [Related]
8. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
Behloul N; Baha S; Shi R; Meng J
Virus Res; 2020 Sep; 286():198058. PubMed ID: 32531235
[TBL] [Abstract][Full Text] [Related]
9. Cell entry mechanisms of SARS-CoV-2.
Shang J; Wan Y; Luo C; Ye G; Geng Q; Auerbach A; Li F
Proc Natl Acad Sci U S A; 2020 May; 117(21):11727-11734. PubMed ID: 32376634
[TBL] [Abstract][Full Text] [Related]
10. Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism.
Othman H; Bouslama Z; Brandenburg JT; da Rocha J; Hamdi Y; Ghedira K; Srairi-Abid N; Hazelhurst S
Biochem Biophys Res Commun; 2020 Jun; 527(3):702-708. PubMed ID: 32410735
[TBL] [Abstract][Full Text] [Related]
11. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Walls AC; Park YJ; Tortorici MA; Wall A; McGuire AT; Veesler D
Cell; 2020 Apr; 181(2):281-292.e6. PubMed ID: 32155444
[TBL] [Abstract][Full Text] [Related]
12. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
13. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2.
Song W; Gui M; Wang X; Xiang Y
PLoS Pathog; 2018 Aug; 14(8):e1007236. PubMed ID: 30102747
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
15. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
Liu Z; Xiao X; Wei X; Li J; Yang J; Tan H; Zhu J; Zhang Q; Wu J; Liu L
J Med Virol; 2020 Jun; 92(6):595-601. PubMed ID: 32100877
[TBL] [Abstract][Full Text] [Related]
16. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.
Hayashi T; Abiko K; Mandai M; Yaegashi N; Konishi I
Vet Q; 2020 Dec; 40(1):243-249. PubMed ID: 32921279
[TBL] [Abstract][Full Text] [Related]
17. Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding.
Adhikari P; Li N; Shin M; Steinmetz NF; Twarock R; Podgornik R; Ching WY
Phys Chem Chem Phys; 2020 Sep; 22(33):18272-18283. PubMed ID: 32756685
[TBL] [Abstract][Full Text] [Related]
18. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV.
Yuan M; Wu NC; Zhu X; Lee CD; So RTY; Lv H; Mok CKP; Wilson IA
Science; 2020 May; 368(6491):630-633. PubMed ID: 32245784
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
[TBL] [Abstract][Full Text] [Related]
20. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.
Letko M; Marzi A; Munster V
Nat Microbiol; 2020 Apr; 5(4):562-569. PubMed ID: 32094589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
